Navigation Links
Schering-Plough Shareholders Approve Merger With Merck
Date:8/7/2009

erations).

DISCLOSURE NOTICE:

The information in this press release and other written reports and oral statements made from time to time by the company may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements do not relate strictly to historical or current facts and are based on current expectations or forecasts of future events. You can identify these forward-looking statements by their use of words such as "anticipate," "believe," "could," "estimate," "expect," "forecast," "project," "intend," "plan," "potential," "will," and other similar words and terms. In particular, forward-looking statements include statements about the timing and potential benefits of the proposed merger between Merck and Schering-Plough; Schering-Plough's and the combined company's strengths; the trending of Schering-Plough's pipeline and business; and other statements that are not historical facts. Actual results may vary materially from the company's forward-looking statements, and there are no guarantees about the performance of Schering-Plough stock or Schering-Plough's business or the combined company's business. Schering-Plough does not assume the obligation to update any forward-looking statement.

A number of risks and uncertainties could cause actual results to differ materially from forward-looking statements, including, among other uncertainties, market viability of the company's and Merck's marketed products and pipeline projects; market forces; economic factors such as interest rate and exchange rate fluctuations; the outcome of contingencies such as litigation and investigations; product availability; patent and other intellectual property protection; current and future branded, generic or over-the-counter competition; the regulatory process (including product approvals, labeling and post-marketing actions); scientific developments r
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Thomson Reuters today ... the first drug pipeline database to fully integrate ... highly anticipated new content is being provided to ... ,, Thomson Pharma will offer drug ... releases, conferences, and other sources across all therapeutic ...
(Date:12/14/2009)... Vermillion, Inc. (Pink Sheets: VRML), ... C. Wallen, Ph.D. Chief Scientific Officer, Senior ... Laboratories, will be joining its board of ... ,, "Bill brings more than 20 ... and biotechnology," said Gail Page, Vermillion Executive ...
(Date:12/14/2009)... Dec. 14 Boston Scientific Corporation (NYSE: ... public offering of $2 billion aggregate principal amount of ... The public offering consists of $850 million of ... 6.00 percent notes due January 2020 and $300 million ... Scientific plans to use the net proceeds for general ...
(Date:12/14/2009)... delivery of Brookfield Engineering’s Powder Flow Tester – helping Brookfield ... smaller footprint and more compact design. , ... ... a US-based thermoforming company, has completed the delivery of Brookfield ... metal to a plastic enclosure with a smaller footprint and ...
Breaking Biology Technology:Thomson Reuters is First to Offer Fully Integrated Pipeline and Clinical Trials 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 2Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 3Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors 4Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 2Boston Scientific Announces Completion of $2 Billion Senior Notes Offering 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2
... China, Nov. 7 /Xinhua-PRNewswire/ -- WuXi PharmaTech ... device research,and development outsourcing company with operations ... that it has signed a new three-year, ... (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ), WuXi ...
... move aside. Tiny gold stars, smaller than a billionth of ... medical diagnoses or testing for environmental contaminants. , While nanoparticles ... a new study by Duke University bioengineers indicates that of ... all the rest for certain applications. , The key ...
... EDMONTON, Nov. 6 /PRNewswire-FirstCall/ - BioMS Medical ... of multiple sclerosis (MS), today,announced financial and operational ... BioMS Medical, in partnership with Eli Lilly and,Company ... the,treatment of MS undergoing pivotal trials in Canada, ...
Other Biology Technology:WuXi PharmaTech Signs New Collaboration Agreement With Pfizer 2Gold nanostar shape of the future 2Gold nanostar shape of the future 3BioMS Medical Announces Third Quarter 2008 Results 2BioMS Medical Announces Third Quarter 2008 Results 3BioMS Medical Announces Third Quarter 2008 Results 4BioMS Medical Announces Third Quarter 2008 Results 5
(Date:12/16/2009)... water is a high priority for grape growers in the southern ... to be irrigated to make it through the growing season. But ... applied to the vines zips right by the plants, hardly even ... water that is applied is lost below the vine rooting zone ... said Eve Hinckley, who worked on the project for her PhD ...
(Date:12/16/2009)... for more than 4 billion years before humans showed ... eons more. That suggests they may have something to ... bacteria expert Prof. Eshel Ben-Jacob of the Raymond and ... the study of bacteria, presents compelling evidence to suggest ... not automatically opt for the swine flu H1N1 shot. ...
(Date:12/16/2009)... DigitalPersona, Inc., a leader in ... an agreement with IBM to deploy a ... technology on IBM SurePOS 500 retail systems. ... applications to more easily and quickly identify ... linked to the individuals who perform them. ...
Breaking Biology News(10 mins):Lost water of the Napa Valley vineyards 2Lost water of the Napa Valley vineyards 3Lost water of the Napa Valley vineyards 4Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3DigitalPersona Fingerprint Sensor Technology Ships on IBM SurePOS 500 Retail Systems 2Mini Stroke Found to Precede 1 in 8 Strokes 58450 1Mini Stroke Found to Precede 1 in 8 Strokes 58450 2Mini Stroke Found to Precede 1 in 8 Strokes 58450 3Profiles International Finds High Employee Utilization is One Key to Maximizing Productivity 58447 1Profiles International Finds High Employee Utilization is One Key to Maximizing Productivity 58447 2Profiles International Finds High Employee Utilization is One Key to Maximizing Productivity 58447 3New Online Continuing Education Course on Near Death Experience Added to HealthForumOnline 26apos 3Bs Library for Mental Health Professionals 58442 1New Online Continuing Education Course on Near Death Experience Added to HealthForumOnline 26apos 3Bs Library for Mental Health Professionals 58442 2New Online Continuing Education Course on Near Death Experience Added to HealthForumOnline 26apos 3Bs Library for Mental Health Professionals 58442 3New Online Continuing Education Course on Near Death Experience Added to HealthForumOnline 26apos 3Bs Library for Mental Health Professionals 58442 4New Online Continuing Education Course on Near Death Experience Added to HealthForumOnline 26apos 3Bs Library for Mental Health Professionals 58442 5
... Mary, University of London have discovered how changes to a ... viral infection which is devastating frog populations across the UK. ... struck down by a foreign virus which is estimated to ... each year. When it strikes garden ponds, the surrounding lawn ...
... p53 protects against cancer and is usually described as ... at the Swedish medical university Karolinska Institutet have now ... activity of p53. As the regulation mechanism is relatively ... the mystery of cancer. , The p53 gene makes ...
... Institute (DFCI) and Source MDx today announced that Source ... predicted survival in men with castration-resistant prostate cancer (CRPC). ... model separated patients into a high risk group (survival ... (survival greater than 2.2 years) (log rank p=0.00083). ...
Other Biology News:Frog's immune system is key in fight against killer virus 2Newly discovered gene plays vital role in cancer 2Dana-Farber oncologists present at ASCO GU -- predict prostate cancer survival using Source MDx test 2